national patient safety goal 3e: anticoagulation- nursing education
TRANSCRIPT
![Page 1: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/1.jpg)
National Patient Safety Goal 3E:Anticoagulation-
Nursing Education
![Page 2: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/2.jpg)
Objectives
• List requirements for meeting standards for the National Patient Safety Goal 3E- Anticoagulation
• Identify risk factors for VTE development in hospitalized patients
• List 3 symptoms of DVT/PE development
• List the 3 patient risk groups for VTE development and 2 appropriate interventions for each risk group
![Page 3: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/3.jpg)
Purpose of National Patient Safety Goals (NPSG):
• Promote specific improvements in patient safety
• Highlight problem areas in health care
• Describe evidence-based solutions
• Focus on system-wide solutions
![Page 4: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/4.jpg)
National Patient Safety Goals
• Goals and Requirements are developed by experts from various fields
• Approved by the Joint Commission's Board in June 2007
• New Goals may be added each year or goals may be continued for more than one year (ex. Med-Rec)
![Page 5: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/5.jpg)
National Patient Safety Goal 3E: Anticoagulation
• Reduce the likelihood of patient harm with the use of anticoagulation (AC) therapy
• Rationale: Anticoagulation therapy is a high risk treatment (due to complexity with dosing, patient compliance with treatment, & monitoring)
![Page 6: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/6.jpg)
Risks with Anticoagulant Therapy
• Anticoagulation medications are listed as one of the top 5 drug classes for patient safety incidents¹
• Reported meds involved in harmful events² include : Heparin, Warfarin, Enoxaparin
• Heparin errors are usually attributed to the non-use of programmable infusion pumps and non-standardized IV concentration of Heparin drips³
1. Cousins D et al. 20062. USP MedMarx data, 20053. Fanikos J. et al. 2004
![Page 7: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/7.jpg)
National Patient Safety Goal 3E: Nuts & Bolts
• Goal applies to the use of heparin, low molecular weight heparins, warfarin and other anticoagulants
• One year phase-in period for all hospitals with full implementation by January 1, 2009
![Page 8: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/8.jpg)
National Patient Safety Goal 3E: Nuts & Bolts
• Requirement for all JCAHO accredited institutions:
– Implement a defined anticoagulation program
– Use ONLY oral Unit Dose products & pre-mixed IV’s
– Warfarin is dispensed for each individual patient with established monitoring
– Use approved protocols for the initiation & maintenance of AC therapy
![Page 9: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/9.jpg)
National Patient Safety Goal 3E: Nuts & Bolts
• Requirement for all JCAHO accredited institutions:
– With the use of Warfarin – baseline/current INR is available for all patients for therapy adjustment
– Dietary services is notified of all pt’s receiving warfarin- food/drug interaction education
– Heparin IV is delivered by a programmable IV pump (MedNet safety pump- in drug library)
– Policy addresses baseline & ongoing lab tests for Heparin/LMWH
![Page 10: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/10.jpg)
National Patient Safety Goal 3E: Nuts & Bolts
• Requirement for all JCAHO accredited institutions:
– Provide education on anticoagulation therapy for all providers, staff, patients, and families
– Pt./family education covers specific areas: follow-up, dietary restrictions, monitoring, complications, and food & drug interactions
– Evaluation of Anticoagulation safety practices
![Page 11: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/11.jpg)
National Patient Safety Goal 3E: Surveying and Scoring
• Joint Commission will evaluate actual performance with standards of the “Goal”
• All requirements must be implemented
• Facility will be found either “Compliant or Not Compliant”
• Failure to comply will result in a “Requirement for Improvement (RFI)”
![Page 12: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/12.jpg)
Venous Thromboembolism (VTE): Prevention and
Anticoagulation Management
![Page 13: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/13.jpg)
The Problem…..
• 2 million Americans will be afflicted with deep vein thrombosis (DVT) each year
• As many as 600,000 will subsequently develop a pulmonary embolism (PE)
• In about 300,000 people the PE may prove to be fatal
• Third most common cause of hospital-related deaths in the U.S.
The most common preventable cause of hospital death
![Page 14: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/14.jpg)
Post-Test Questions
![Page 15: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/15.jpg)
$$$ Economic burden of VTE $$$
• Cost of care related to VTE (cases of DVT and PE together) in the U.S. each year is estimated at 1.5 billion
• Post-op thromboembolic complications add an average of $18,300 to the total hospital costs for each patient in which they happen
![Page 16: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/16.jpg)
Risk Factors for VTE development
– Decreased mobility
– Age (especially >75)
– Personal history of DVT/PE or clotting disorder
– Surgery- LE joint replacement open abdominal, urologic, or gynecologic procedure
– Inflammatory conditions
– Current malignancy
– Estrogen therapy or pregnancy
– History of MI, CHF, COPD, or other respiratory failure
– Stroke < 1 month
– Admission to the ICU
– Sepsis
Venous Thromboembolism Prophylaxis, June 2007, ICSI
![Page 17: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/17.jpg)
Causes for VTE development• Venous stasis- immobility
• Vein injury- surgery, IV therapy, phlebotomy
• Increased coagulation- cancer, inflammatory conditions or infectious process
Virchow’s Triad
![Page 18: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/18.jpg)
Bed Rest!! … a DVT/ PE Red Flag!!!
BEDREST
![Page 19: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/19.jpg)
Signs and symptoms of DVT or PE
• Pain, cramps or heaviness in affected extremity
• Parathesias- unexplained numbness or tingling
• Redness and edema of affected extremity
• Tenderness and pain in calf upon palpation
• Shortness of breath
• Chest heaviness (without cardiac explanation)
• Sense of “impending doom”
![Page 20: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/20.jpg)
DVT Prophylaxis: 3 Patient Groups
Low risk
Highest risk
Moderate/High risk
![Page 21: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/21.jpg)
• Patient Group:– Age <60– Minor surgical procedure– Medical patient on bedrest– Pregnant patient or patient on oral contraceptives or
hormone replacement
• Recommendations for prophylaxis:– Early ambulation- this means up walking in hallway 2-
3 times per day– SCD’s while in bed
Low risk
![Page 22: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/22.jpg)
• Patient Group:– Age >60
– Central venous access
– History of previous malignancy
– History of medical risk factors CHF, COPD, inflammatory bowel disease
– Medical patient with additional risk factors (CHF, COPD, Sepsis, MI)
– Major surgery planned with additional risk factors
• Recommendations:– Early ambulation- this means up walking in hallway 2-3 times per day
– SCD’s while in bed
– Enoxaparin 40mg subQ every day start 12-24 hrs. after surgery
– If orthopedic patient- follow orthopedic anticoagulation protocol
Moderate/High risk
![Page 23: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/23.jpg)
• Patient Group:– Age >75– Elective hip or knee surgery– Active cancer– Hip, pelvis or leg fracture (<1 month)– Stroke (<1 month)– Admission to ICU– Personal hx. of DVT, PE or clotting disorder
• Recommendations:– Early ambulation- this means up walking in hallway 2-3 times per
day– SCD’s while in bed– Enoxaparin 40mg subQ every day start 12-24 hrs. after surgery– If orthopedic patient- follow orthopedic anticoagulation protocol
Very High Risk
![Page 24: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/24.jpg)
Medical Condition Risk DVT
Condition Risk of DVT
General Medical 10%-26%
MI 17%-34%
Stroke 11%-75%
CHF 20%-40%
Medical ICU 35%-42%
Chest 2005; 128;958-969
![Page 25: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/25.jpg)
Prevention techniques
• Risk assessment tools- – Providers to risk stratify patients into risk
categories based on current diagnosis and previous medical history (VTE Order Set PO 1190)
• Early ambulation
• Medication prophylaxis if indicated based on patient’s VTE risk level
Venous Thromboembolism Prophylaxis, June 2007, ICSI
![Page 26: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/26.jpg)
Contraindications to drug therapy
• Active, significant bleeding
• Extreme thrombocytopenia (<50,000)
• History of heparin induced thrombocytopenia (HIT)
• Uncontrolled hypertension (SBP >200, DBP >120)
• Patient with bacterial endocarditis
• Patient with active hepatitis or hepatic insufficiency
Venous Thromboembolism Prophylaxis, June 2007, ICSI
![Page 27: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/27.jpg)
New HCD DVT/PE Assessment screens
• New DVT/PE assessment screens have been built in HCD- will replace “Homan’s assessment” under muskuloskeletal body system
• This assessment is under the “FLOWSHEET” tab in HCD
• The DVT/PE assessment will be completed with all nursing assessments
![Page 28: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/28.jpg)
New HCD DVT/PE Assessment screens
• The DVT/PE assessment includes:– Calf assessment for pain, redness, warmth,
tenderness or swelling– Respiratory signs & symptoms of SOB or
difficulty breathing– Includes area for documentation of “MD
NOTIFICATION” if patient has any of the above present
![Page 29: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/29.jpg)
New HCD DVT/PE Assessment Screens
![Page 30: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/30.jpg)
New HCD DVT/PE Assessment screens
![Page 31: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/31.jpg)
New HCD DVT/PE Assessment screens
![Page 32: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/32.jpg)
New HCD DVT/PE Education screens
• New DVT/PE Education screens have been built in HCD (requirement to meet NPSG 3E standards)
• Documentation is under the “EDUCATION” tab in HCD
• The DVT/PE education will be completed and documented at least once during the hospitalization (requirement to meet NPSG 3E standards)
• Discharge RN must verify that DVT/PE education has been documented on the patient
• Enoxaparin and Coumadin Patient Education Written materials have been updated and will no longer require for nursing to document on these
![Page 33: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/33.jpg)
New HCD DVT/PE Education screens
• For Bethesda only- Nursing will continue to document on the brown border education flowsheet
• The DVT/PE education includes:
– Patient education on diagnosis of DVT/PE or preventative information
– Documentation of consult to Dietician for additional drug/food interaction education (checking this tab will not automatically place order for consult- the consult must be manually entered)
– Patient/family education on Sx. of PE/DVT, medications, medication purpose, food/drug interactions, drug monitoring, and Lovenox demo
– Written or video education on coumadin and/or Lovenox
![Page 34: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/34.jpg)
New HCD DVT/PE Education screens
![Page 35: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/35.jpg)
New HCD DVT/PE Education screens
![Page 36: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/36.jpg)
New HCD DVT/PE Education screens
![Page 37: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/37.jpg)
New HCD DVT/PE Education screens
![Page 38: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/38.jpg)
New HCD DVT/PE Education screens
![Page 39: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/39.jpg)
HealthEast’s work on VTE Prevention
& Anticoagulant Management
• Aims (What are we trying to accomplish?)
– Reduce the incidence of DVT and PE in hospitalized patients by 50% in one year.
– Reduce readmissions within 31 days for DVT and PE by 50% in one year.
– Reduce patient harm associated with the use of anticoagulant therapy by 50% in one year.
![Page 40: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/40.jpg)
HealthEast’s work on VTE Prevention
& Anticoagulant Management
• Measures (How will we know that a change is an improvement?)
– Hospital Acquired DVT per 1000 Discharges
– Hospital Acquired PE per 1000 Discharges
– Readmissions within 31 Days with DVT per 1000 Discharges
– Readmissions within 31 Days with PE per 1000 Discharges
– Patient harm associated with anticoagulant therapy as measured by the IHI Adverse Drug Event Trigger Tool
![Page 41: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/41.jpg)
DVT Prevention
• Clinical Goals:
– Adult patients (18 & older) are assessed for VTE (DVT & PE) risk within 24 hours of admission
– Appropriate pharmacological and/or mechanical prophylaxis begins within 24 hrs of admission
– All patients receive education regarding VTE signs & symptoms, preventive methods
– All patients begin early and frequent ambulation
Venous Thromboembolism Prophylaxis, June 2007, ICSI
![Page 42: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/42.jpg)
DVT Prevention
• Clinical Goals:
– All adult medical/surgical patients with moderate-high or very high VTE risk receive anticoagulation prophylaxis unless contraindicated
– Reduce the risk of complications from pharmacologic prophylaxis.
Venous Thromboembolism Prophylaxis, June 2007, ICSI
![Page 43: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/43.jpg)
DVT Prevention
• Clinical Goals:
– Appropriate pharmacological and/or mechanical prophylaxis begins within 24 hrs of admission
– Mechanical prophylaxis is used when pharmacologic prophylaxis is contraindicated
– Appropriate precautions for patients receiving spinal or epidural anesthesia are implemented
Venous Thromboembolism Prophylaxis, June 2007, ICSI
![Page 44: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/44.jpg)
Future steps……
• Development of a VTE Dashboard with all system measures for each site
• Creation of a VTE Collaborative Practice Committee with participation by all site leads
• Continue assessing progress with VTE work at each site
• Yearly nursing, pharmacy and provider education (requirement for NPSG 3E)
![Page 45: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/45.jpg)
NPSG 3E: Anticoagulation- References
For more information, see the Joint Commission Website:
www.jointcommission.org
1. Cousins D et al. 2006. Risk assessment of anticoagulation therapy. National Patient Safety Agency. United Kingdom
2. USP MedMarx data, 2005
3. Fanikos J. et al. Medication errors associated with anticoagulant therapy in the hospital. Am J Cardiol. 2004; 94: 532-5.
4. ICSI Venous Thromboembolism Prophylaxis Fourth Edition-June 2007
5. Chest 2005; 128;958-969
6. Santell JP, Hicks RW, Cousins DD. MEDMARX Data Report: A Chart-book of 2000-2004 Findings from Intensive Care Units and Radiological Services. Rockville, MD: USP Center for the Advancement of Patient Safety; 2005
![Page 46: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/46.jpg)
Post-Test Questions
1. Which of the following are requirements for meeting the NPSG 3E standards?
a. Yearly nursing, pharmacy and provider education
b. Warfarin dosing for all patients will only be managed by pharmacy
c. Defined hospital anticoagulation management program
d. Dietary notification of all patient’s receiving warfarin
e. Answers A, C, D
![Page 47: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/47.jpg)
2. Which are risk factors for VTE development?
a. decreased mobility, obesity, and sepsis
b. Decreased mobility, joint, surgery, and history of DVT/PE
c. decreased mobility, age >40, and history of CHF
d. Cancer, age >40, and pregnancy
![Page 48: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/48.jpg)
3. Which are symptoms of DVT/PE development?
a. SOB and anxiety
b. Chest heaviness (without cardiac explanation) and bruising of extremity
c. Tenderness/pain upon palpation of calf and SOB
d. Redness/edema of extremity and high INR
![Page 49: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/49.jpg)
4. What are the risk factors for the “Very High” Patient group?
a. age >60, active cancer, and history of CHF
b. age >60, central venous access, and major abdominal surgery
c. age >75, bedrest, and minor surgical procedure
d. age >75, active cancer and admission to ICU
![Page 50: National Patient Safety Goal 3E: Anticoagulation- Nursing Education](https://reader030.vdocuments.mx/reader030/viewer/2022032517/56649ca25503460f9496226f/html5/thumbnails/50.jpg)
5. What must be documented on discharge for DVT/PE patient education?a. diagnosis or preventative information, sx. Of
DVT/PE, medications, and food/drug interactionsb. diagnosis or preventative education, activity,
diet, and food/drug interactionsc. Home monitoring, food/drug interactions and
follow-up appointmentsd. Food/drug interactions, outpatient therapy, and
medications